Genus Capital Management Inc. Bristol Myers Squibb CO Transaction History
Genus Capital Management Inc.
- $690 Billion
- Q1 2025
A detailed history of Genus Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Genus Capital Management Inc. holds 19,990 shares of BMY stock, worth $1 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
19,990
Previous 28,830
30.66%
Holding current value
$1 Million
Previous $1.63 Billion
25.23%
% of portfolio
0.18%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,783Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.54 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.96 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.82 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.78 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.03 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...